Physiologic-based strategies for protein drug delivery to the brain

Journal of Controlled Release

Volumn 39, Issue 2-3, 1996, Pages 281-286

  Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Avidin; Biotin; Blood brain barrier; Vasoactive intestinal peptide

Indexed keywords

AVIDIN; BIOTIN; LIPOSOME; MONOCLONAL ANTIBODY; PEPTIDE; RECOMBINANT PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

BLOOD BRAIN BARRIER; CONFERENCE PAPER; DRUG ACTIVITY; DRUG COMBINATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DEVELOPMENT; PHARMACEUTICS; PRIORITY JOURNAL; TRANSCYTOSIS;

EID: 0029975193     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00161-1     Document Type: Conference Paper

References (24)

1. W.M. Pardridge, Vector-mediated peptide drug delivery to the brain. Adv. Drug Deliv. Rev. 15 (1995) 109-146.
2. E.A. Neuwelt and S.I. Rapoport. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed. Proc. 43 (1984) 214-219.
3. P.C. Warnke, R.G. Blasberg and D.R. Groothuis, The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas. Ann. Neurol. 22 (1987) 300-305.
4. 4 selectively increases blood-brain barrier permeability after focal ischemia in rats, J. Cerebral Blood Flow Metab. 11 (1991) 638-643.
5. R.G. Blasberg, C. Patlak and J.D. Fenstermacher, Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion. J. Pharmacol. Exp. Ther. 195 (1975) 73-83.
6. W.M. Pardridge, Peptide Drug Delivery to the Brain, Raven Press, New York, NY, 1991.
7. A.V. Kabanov, V.P. Chekhonin, V.Y. Alakhov, E.V. Batrakova, A.S. Lebedev, N.S. Melik-Nubarov, S.A. Arzhakov, A.V. Levashov, G.V. Morozov, E.S. Severin et. al., The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 258 (1989) 343-345.
8. V.P. Chekhonin, A.V. Kabanov, Y.A. Zhirkov, and G.V. Morozov, Fatty acid acylated Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain, FEBS Lett. 287 (1991) 149-152.
9. R. Gennuso, M.K. Spigelman, M. Chinol, R.A. Zappulla, J. Nieves, S. Vallabhajosula, P.A. Paciucci, S.J. Goldsmith and J. F. Holland, Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake, Cancer Invest. 11 (1993) 118-128.
10. V.A. Levin, Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability, J. Med. Chem. 23 (1980) 682-684.
11. W.M. Pardridge, J. Yang, J. Buciak and Y.-S. Kang, Cationized human immunoglobulins as a treatment for cerebral AIDS: evaluation of pharmacokinetics, efficacy, and toxicity in scid mice, Soc. Neurosci. Abstr., 21 (1995) 1751.
12. U. Bickel, Y.-S. Kang, T. Yoshikawa and W.M. Pardridge, In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate within brain capillary endothelium, J. Histochem. Cytochem. 42 (1994) 1493-1497.
13. A.W. Jeffries, M.R. Brandon, A.F. Williams and S.V. Hunt, Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor, Immunology 54 (1985) 333-341.
14. W.A. Jeffries, M.R. Brandon, S.V. Hunt, A.F. Williams, K.C. Gatter and D.Y. Mason, Transferrin receptor on endothelium of brain capillaries, Nature 312 (1984) 162-163.
15. W.M. Pardridge, J. Eisenberg and J. Yang, Human blood-brain barrier transferrin receptor. Metabolism 36 (1987) 892-895.
16. J.B. Fishman, J.B. Ruben, J.V. Handrahan, J.R. Connor and R.E. Fine, Receptor-mediated transcytosis of transferrin across the blood-brain barrier, J. Neurosci. Res. 18 (1987) 299-304.
17. W.M. Pardridge, Y.-S. Kang, J.L. Buciak and J. Yang, Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate, Pharm. Res. 12 (1995) 807-816.
18. A.K. Kumagai, J. Eisenberg and W.M. Pardridge, Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport, J. Biol. Chem. 262 (1987) 15214-15219.
19. Y.-S. Kang and W.M. Pardridge, Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate, J. Pharmacol. Exp. Ther. 269 (1994) 344-350.
20. U. Bickel, Y.-S. Kang and W.M. Pardridge, In vivo cleavage of a disulfide-based chimeric opioid peptide in rat brain, Bioconj. Chem. 6 (1995) 211-218.
21. U. Bickel, T. Yoshikawa, E.M. Landaw, K.F. Faull and W.M. Pardridge, Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery, Proc. Natl. Acad. Sci. USA 90 (1993) 2618-2622.
22. M. Andersson, J.-C. Marie, M. Carlquist and V. Mutt, The preparation of biotinyl-ε-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor. FEBS Lett. 282 (1991) 35-40.
23. T. Itakura, T. Okuno, K. Nakakita, I. Kamei, Y. Naka, K. Nakai, H. Imai, N. Komai, H. Kimura and T. Maeda, A light and electron microscopic immunohistochemical study of vasoactive intestinal polypeptide-and substance p-containing nerve fibers along the cerebral blood vessels: comparison with aminergic and cholinergic nerve fibers, J. Cerebral Blood Flow Metab. 4 (1984) 407-414.
24. J. McCulloch and L. Edvinsson, Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide, Am. J. Physiol. 238 (1980) H449-H456.